News
Brokerage firms have varying outlooks on several companies. JP Morgan downgraded Tata Technologies due to mixed Q1 results, while Goldman Sachs is optimistic about Ola Electric's path to profitability ...
U.S. inspectors have found new breakdowns at a Sun Pharmaceuticals plant in India that produces medications for U.S. customers, ProPublica reported July 16. The FDA found the factory failed to ...
Megan Rose and Debbie Cenziper ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our ...
Trackonomy reports cargo theft is a rising issue in supply chains, costing billions while advanced technology helps combat ...
Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.
The FDA cracked down on two plants in India and one in Korea in separate recently released reports, citing issues ranging ...
Explore more
From my colleague Drew Joseph: Ahead of an advisory committee meeting Thursday focused on GSK’s multiple myeloma drug Blenrep, the FDA pointed to concerns about the high rates of eye issues that have ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
A new study published in the Canadian Medical Association Journal (CMAJ) confirms what many suspected: obesity rates in Canada have surged since the onset of the pandemic. Prior to 2020, the trend was ...
A Japanese man was sentenced Wednesday to three and a half years in prison in China on espionage charges, according to the ...
Stock Market Today: Indian equities rebounded strongly on Tuesday, 15 July, snapping a four-day losing streak as broad-based ...
Sun Pharmaceutical Industries Ltd. closed 13.23% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results